ClassID:

93324

C07C307/06 - CPC Classification

Classification description:

Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups; Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to acyclic carbon atoms

Recent Application in this class:
#1
20250367299
2025-12-04

GAMMA-HYDROXYBUTYRATE DELIVERING COMPOUNDS AND PROCESSES FOR MAKING AND USING THEM

#2
20250325711
2025-10-23

COVALENT FLUORESCENT PROBES FOR CANNABINOID RECEPTOR 2

#3
20250186591
2025-06-12

GAMMA-HYDROXYBUTYRATE DELIVERING COMPOUNDS AND PROCESSES FOR MAKING AND USING THEM

#4
20240373847
2024-11-14

HERBICIDAL MALONAMIDES

#5
20240293318
2024-09-05

CLEAVABLE LINKER-CONTAINING IONIZABLE LIPIDS AND LIPID CARRIERS FOR THERAPEUTIC COMPOSITIONS

#6
20240097191
2024-03-21

Electrolyte solution additive containing isocyanate and sulfamide structural groups and application thereof

#7
20230416211
2023-12-28

Compounds and compositions for treating conditions associated with NLRP activity

#8
20230382880
2023-11-30

Gamma-hydroxybutyrate delivering compounds and processes for making and using them

#9
20230382851
2023-11-30

GAMMA-HYDROXYBUTYRATE DELIVERING COMPOUNDS AND PROCESSES FOR MAKING AND USING THEM

#10
20230338543
2023-10-26

GAMMA-HYDROXYBUTYRATE DELIVERING COMPOUNDS AND PROCESSES FOR MAKING AND USING THEM

#11
20230091121
2023-03-23

CALPAIN-2 INHIBITOR COMPOUNDS AND METHODS OF TREATMENT

#12
20230062815
2023-03-02

Compounds and compositions for treating conditions associated with NLRP activity

#13
20230061429
2023-03-02

Bicyclic compounds

#14
20210171477
2021-06-10

Compounds and compositions for treating conditions associated with NLRP activity

#15
20200347011
2020-11-05

Double-headed protease inhibitor

#16
20180346416
2018-12-06

N-SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF

#17
20180343870
2018-12-06

Preparation of sulfonamide-containing antimicrobials and substrate treating compositions of sulfonamide-containing antimicrobials

#18
20180244663
2018-08-30

Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor

#19
20180086697
2018-03-29

Inhibitors of human immunodeficiency virus replication

#20
20180072997
2018-03-15

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#21
20170355805
2017-12-14

Ionic diol, antistatic polyurethane, and method of making the same

#22
20160297754
2016-10-13

N-substituted benzamides and methods of use thereof

#23
20160272581
2016-09-22

Phenylcarbamate derivatives as formyl peptide receptor modulators

#24
20160221996
2016-08-04

Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor

#25
20160002186
2016-01-07

Methods and intermediates for preparing pharmaceutical agents

#26
20150329482
2015-11-19

Preparation of 13-Cyclohexyl-3-Methoxy-6-[Methyl-(2-(2-[Methyl-(Sulphamoyl)-Amino]-Ethoxy}-Ethyl)-Carbamoyl]-7H-Indolo-{2,1-a]-[2]-Benzazepine-10-Carboxylic Acid

#27
20150322002
2015-11-12

N-substituted benzamides and methods of use thereof

#28
20150291514
2015-10-15

N-Aminosulfonyl Benzamides

#29
20150133674
2015-05-14

Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor

#30
20150005493
2015-01-01

Methods and intermediates for preparing pharmaceutical agents

#31
20140315879
2014-10-23

Sulfonamide derivatives

#32
20140179687
2014-06-26

Inhibitors of cyclophilins and uses thereof

#33
20140088304
2014-03-27

Methods and intermediates for preparing pharmaceutical agents

#34
20140031331
2014-01-30

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

#35
20130317001
2013-11-28

N-substituted benzamides and methods of use thereof

#36
20130317000
2013-11-28

N-substituted benzamides and methods of use thereof

#37
20130253022
2013-09-26

NOVEL FLUORINATED SULFAMIDES EXHIBITING NEUROPROTECTIVE ACTION AND THEIR METHOD OF USE

#38
20130184279
2013-07-18

N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases

#39
20130184238
2013-07-18

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

#40
20130102777
2013-04-25

Preparation of 13-cyclohexyl-3-methoxy-6-[methyl-(2-{2-[methyl-(sulphamoyl)-amino]-ethoxy}-ethyl)-carbamoyl]-7-indolo-[2,1-]-[2]-benzazepine-10-carboxylic acid

#41
20130102609
2013-04-25

Biaryl oxyacetic acid compounds

#42
20130018044
2013-01-17

Inhibitors of cyclophilins and uses thereof

#43
20120302546
2012-11-29

NOVEL SULFAMIDES EXHIBITING NEUROPROTECTIVE ACTION AND METHODS FOR USE THEREOF

#44
20120271049
2012-10-25

Bifunctional phenyl iso(thio)cyanates, processes and intermediates products for their preparation

#45
20120263714
2012-10-18

SUBSTITUTED HALOPHENOXYBENZAMIDE DERIVATIVES

#46
20120202854
2012-08-09

4-substituted phenoxyphenylacetic acid derivatives

#47
20120164582
2012-06-28

Radiation-sensitive composition and compound

#48
20120101271
2012-04-26

DIAMINE SYNTHESIS VIA CATALYTIC C-H AMINATION OF AZIDES

#49
20120046292
2012-02-23

DIACYLETHYLENEDIAMINE COMPOUND

#50
20110044918
2011-02-24

Sulfamide derivatives and cosmetic use thereof

#51
20110039819
2011-02-17

SUBSTITUTED PHENOXYBENZAMIDES

#52
20110009640
2011-01-13

Bifunctional phenyl ISO (THIO) cyanates, processes and intermediates for their preparation

#53
20100273739
2010-10-28

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

#54
20100256366
2010-10-07

Methods and intermediates for preparing pharmaceutical agents

#55
20100222586
2010-09-02

Methods for producing sulfonic acid diamides

#56
20100210603
2010-08-19

NOVEL SULFONAMIDE INHIBITORS OF ASPARTYL PROTEASE

#57
20100179224
2010-07-15

Acyclic sulfamide derivatives

#58
20100173955
2010-07-08

4-substituted phenoxyphenylacetic acid derivatives

#59
20100061936
2010-03-11

Unnatural amino acids capable of covalently modifying protein phosphatases and their use as general and specific inhibitors and probes

#60
20100048712
2010-02-25

Acyclic Sulfamide Derivatives

#61
20100041892
2010-02-18

Therapeutic agent for diabetes

#62
20100041717
2010-02-18

N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases

#63
20100035930
2010-02-11

Urea and sulfamide derivatives as inhibitors of TAFIa

#64
20090270631
2009-10-29

Therapeutic agent for diabetes

#65
20090221710
2009-09-03

Acyclic Sulfamide Derivatives

#66
20090176996
2009-07-09

PROCESS FOR THE PREPARATION OF SULFAMIDE DERIVATIVES

#67
20080293727
2008-11-27

Novel sulfonamide inhibitors of aspartyl protease

#68
20080293701
2008-11-27

1-Acylamino-2-Hydroxy-3-Amino- -Arylalkanes as Renin Inhibitors

#69
20080096922
2008-04-24

Novel Sulfonamide derivative

#70
20080009530
2008-01-10

Therapeutic Agent for Diabetes

#71
20070299080
2007-12-27

Benzamide derivatives and uses related thereto

#72
20070297941
2007-12-27

Organic peroxyacid precursors

#73
20070293530
2007-12-20

SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS

#74
20070219192
2007-09-20

Certain chemical entities, compositions, and methods

#75
20070179183
2007-08-02

N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists

#76
20070037814
2007-02-15

ACYLSULFAMIDE INHIBITORS OF FACTOR VIIa

#77
20070021442
2007-01-25

HIV reverse transcriptase inhibitors

#78
20060270856
2006-11-30

Process for preparation of sulfamide derivatives

#79
20060189810
2006-08-24

Sulfonamide inhibitors of aspartyl protease

#80
20060134151
2006-06-22

Sulfamide derivatives and cosmetic use thereof

#81
20060094789
2006-05-04

α- and β-amino acid hydroxyethlamino sulfonyl urea derivatives useful as retroviral protease inhibitors

#82
20060047001
2006-03-02

Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents

#83
20060020009
2006-01-26

Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors

#84
20060004220
2006-01-05

Bifunctional phenyliso(thio)cyanates, processes and intermediates products for their preparation

#85
20050282872
2005-12-22

Thyroid receptor ligands and method II

#86
20050267214
2005-12-01

α- and β-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors

#87
20050148473
2005-07-07

Substituted sulfonylaminomethylbenzoic acid (derivatives) and their preparation